VAERS reports by lot

Moderna COVID-19 lot 03B21A: VAERS reports

44 VAERS reports list lot 03B21A as a Moderna COVID-19 vaccine, received between 2021-03-19 and 2023-07-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
44
Reports
11%
Marked serious
1
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4028%
Neurological2920%
Gastrointestinal2014%
Cardiac / Cardiovascular128%
Musculoskeletal107%
Injection-site / Local reaction107%
Respiratory96%
Dermatological (non-injection-site)86%
Allergic / Anaphylactic32%
Psychiatric / Neuropsychiatric32%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois4
Colorado4
California4
Ohio3
Kentucky3
Oklahoma2
Florida2
Texas1
Mississippi1
Connecticut1
New York1
Nevada1

Reports by month received

2021-032
2021-0413
2021-058
2021-062
2021-072
2021-086
2021-092
2021-102
2021-111
2021-122
2022-021
2022-041
2022-051
2023-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.